- Emis Group said that trading for the year to date was in line with its expectations as it continued to make progress on it medium-term growth plan.

'The Board of EMIS Group, the UK leader in connected healthcare software and services, is pleased to announce that trading for the year to date is in line with the Board's expectations,' the company said.

As reported on 20 March 2019 at the time of its 2018 annual results, the group continued to have high levels of recurring revenue and remained in a 'strong' financial position, EMIS said.

'The Group is focused on the execution of its strategy as set out at its Capital Markets Day in November 2018, with the recent disposal of the non-core Specialist & Care business representing an important step towards focusing the Group on its medium-term growth plan,' it added.

'To support the realigned business, the Group is deploying improved internal systems, which are expected to drive greater efficiencies during 2019 and beyond.'

The pre-procurement engagement with NHS Digital continued 'positively,' with the formal GP IT Futures procurement process expected to begin in the coming weeks, the company said.

The level of development resource dedicated to EMIS-X had increased as planned, and this 'key technology project remained on track.' 'In Patient, trials of the new platform app will begin shortly, ahead of the wider marketplace launch in the second half of the year.'

'The Board remains confident of making further progress in delivering EMIS Group's vision of driving greater integration and efficiency in healthcare, both for the NHS and the Group's enterprise customers.'

At 10:08am: [LON:EMIS] EMIS Group PLC share price was 0p at 1154p

Story provided by